Skip to content

GLASS Classification and CLTI

The Relationship Between the Global Limb Anatomic Staging System (GLASS) and Short Term Outcomes of Endovascular Management of Infrainguinal Lesions in Patients With Chronic Limb Threatening Ischemia (CLTI)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05209672
Enrollment
36
Registered
2022-01-26
Start date
2022-03-31
Completion date
2023-03-31
Last updated
2022-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities

Brief summary

Critical limb threatening ischemia CLTI 'is not a separate local disease but also it is a part of generalized vascular disorder. A clinical syndrome that can be presented by many symptoms and signs as rest pain, gangrene and chronic ulceration more than 2 weeks (1).

Detailed description

The Global Vascular guidelines 'GVG proposes a new Global Anatomic Staging System (GLASS), GLASS incorporates two novel and important concepts, the target arterial path (TAP) and estimated limb-based patency (LBP). Based on appropriate angiographic imaging, the TAP is defined by the treating surgeon or internationalist as the optimal arterial pathway to restore in-line (pulsatile) flow to the ankle and foot. LBP allows more direct comparison of anatomic outcomes across revascularization strategies in CLTI. The complexity of disease traversed by the TAP is integrated in the GLASS. Femoropopliteal (FP) and infrapopliteal (IP) arterial segments are individually graded on a scale of 0 to 4.(2)(3) Using a consensus based matrix, these segmental grades are combined into three overall GLASS (I-III) stages for the limb, reflecting the complexity of the disease with a proposed likelihood of immediate technical failure ' ITF and 1 year LBP after endovascular intervention of TAP ' (1)

Interventions

None listed

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients with infrainguinal CLTI

Exclusion criteria

* Patients with concomitant Aorto-iliac lesions * Acute ischemia patients * Post Traumatic ischemia

Design outcomes

Primary

MeasureTime frameDescription
Imitate technical failure1 yearFailure of passage of wire or Recoil of vessels during angioplasty
Limb based patency at 1 year1 yearPatent vessels after endovascular management

Secondary

MeasureTime frameDescription
Amputation free survival at 1 year1 yearLimb preserved after endovascular intervention
Mortality Rate at 1 year1 yearDeath after endovascular intervention
Amputation rate at 1 year1 yearAmputation after endovascular intervention

Countries

Egypt

Contacts

Primary ContactHaitham Ali Hassan, MD
Haithamvascular@gmail.com01006770588
Backup ContactAyman Elsayed Hassaballah, MD
aymanhasaballa@yahoo.com0106647688

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026